Showing 581-590 of 3058 results for "".
Innovations in Parkinson's Disease: Deep Brain Stimulation and Magnetic Resonance-guided Focused Ultrasound
https://practicalneurology.com/diseases-diagnoses/movement-disorders/innovations-in-parkinsons-disease-deep-brain-stimulation-and-magnetic-resonance-guided-focused-ultrasound/30500/Rapid progress in deep brain stimulation and focused ultrasound offer a glimpse of the future of treatment for Parkinson's disease.The Approval of PFO Closure in the United States
https://practicalneurology.com/diseases-diagnoses/stroke/the-approval-of-pfo-closure-in-the-united-states/30295/A look back at the long road to FDA approval and the implications on patient care options going forward.Reproductive Issues for Patients With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/reproductive-issues-for-patients-with-multiple-sclerosis/30215/The prototypic patient with multiple sclerosis is a young woman of childbearing age, which makes reproductive issues extremely important.LGI1 Antibody Encephalitis Presenting as Focal Cortical Encephalitis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/lgi1-antibody-encephalitis-presenting-as-focal-cortical-encephalitis-1/32135/Individuals with LGI1 antibody encephalitis may present with atypical symptoms, requiring a comprehensive diagnostic work-up and vigilance by clinicians.Disparities in Alzheimer Disease and Alzheimer-Related Dementias: Considerations for Clinical Decision-Making and Treatment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disparities-in-alzheimer-disease-and-alzheimer-related-dementias-considerations-for-clinical-decision-making-and-treatment/32016/Taking into account social determinants of health and identifying solutions to improve patient care.Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Headache Horizons: Recognition, Diagnosis, and Treatment of Hypnic Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-recognition-diagnosis-and-treatment-of-hypnic-headache/32060/Hypnic headache, also known as alarm clock headache, is a rare, under-recognized cause of nighttime headache attacks that can be treated with melatonin, caffeine, or lithium.Cannabinoids and Psychedelics for Headache Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-psychedelics-for-headache-management/32131/Reports of success in self-treatment of primary headache disorders with cannabis and psilocybin have led to clinical trials studying their efficacy and safety.Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Blood Pressure Targets After Stroke: How Low Is Too Low?
https://practicalneurology.com/diseases-diagnoses/stroke/blood-pressure-targets-after-stroke-how-low-is-too-low/49161/Acute hypertensive response management after stroke is a dynamic process that requires careful integration of clinical trial evidence, pathophysiologic principles, imaging findings, and patient-specific factors.